Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche, McKinsey and OrbiMed Launch First Life Sciences Business Plan Competition In Shanghai

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Swiss-headquartered Roche, business consulting company McKinsey and venture capitalist OrbiMed co-launched Dec.10 their Shanghai SEED competition to foster entrepreneurs in China's life sciences sector

You may also be interested in...



Roche, OrbiMed And McKinsey's Entrepreneurship Competition Builds Platform For China's Young Biotech Community

SHANGHAI - Seeking ways to tap into China's rich talent pool and spark local innovation, Roche, OrbiMed and McKinsey are hoping a SEED business competition can nurture entrepreneurs in China's biotech academic community

Roche, OrbiMed And McKinsey's Entrepreneurship Competition Builds Platform For China's Young Biotech Community

SHANGHAI - Seeking ways to tap into China's rich talent pool and spark local innovation, Roche, OrbiMed and McKinsey are hoping a SEED business competition can nurture entrepreneurs in China's biotech academic community

PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter

BEIJING - As part of a rapid-fire expansion across Asia, the U.S.-headquartered PPD has outlined plans to purchase and merge with the Beijing-based contract research organization BioDuro

Related Content

UsernamePublicRestriction

Register

SC070576

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel